Burning Rock Biotech Working Capital Growth & History (BNR)
Burning Rock Biotech's working capital was $70.3M for fiscal 2025.
View full Burning Rock Biotech company overviewBurning Rock Biotech annual working capital history
| Fiscal year | Period ended | Working capital | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $70.3M | $385,000 | +0.55% |
| 2024 | 2024-12-31 | $69.9M | −$17.5M | −20.03% |
| 2023 | 2023-12-31 | $87.4M | −$35.4M | −28.83% |
| 2022 | 2022-12-31 | $122.8M | −$104.5M | −45.96% |
| 2021 | 2021-12-31 | $227.3M | −$122.4M | −35.00% |
| 2020 | 2020-12-31 | $349.8M | — | — |
Burning Rock Biotech quarterly working capital
| Fiscal quarter | Period ended | Working capital | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $70.3M | $385,000 | +0.55% |
| Q4 2024 | 2024-12-31 | $69.9M | −$17.5M | −20.03% |
| Q4 2023 | 2023-12-31 | $87.4M | −$35.4M | −28.83% |
| Q4 2022 | 2022-12-31 | $122.8M | −$104.5M | −45.96% |
| Q2 2022 | 2022-06-30 | $164.8M | — | — |
| Q4 2021 | 2021-12-31 | $227.3M | −$122.4M | −35.00% |
| Q4 2020 | 2020-12-31 | $349.8M | — | — |
Burning Rock Biotech working capital trends
Over the last five fiscal years, Burning Rock Biotech's working capital decreased from $349.8M to $70.3M, a change of −$279.5M. The latest reported quarter, Q4 2025, shows $70.3M.
What working capital means
Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.
How working capital is calculated
TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Burning Rock Biotech source filings ↗